September 30, 2016
Video screening, Q&A and discussion. STUDENTS: Join us for a screening of SaskCanola’s documentary “License to Farm†followed by a discussion with some of the experts featured in the video! Social license is a fascinating and complex topic which can affect research funding and policy, and maybe YOUR career! Join the conversation!
September 27, 2016
Plan to attend the 2016 Global Biotechnology Week Breakfast. Canada is home to a vibrant biotech industry of more than 500 established and emerging companies. These companies are driving solutions for the challenges identified with global population growth including vaccines protecting against cancer, green chemicals offering options for environmental stewardship, and more sustainable farming practices to secure food supply. It is an industry of great diversity with an array of entities including large, multinational companies as well as numerous small and medium sized companies.
September 27, 2016
2016 is a turning point for orphan drugs and for neonatal screenings. In Europe the benefit of orphan drug designation is debated, whilst in Italy a scientific inclusive environment is pushing for the finalisation of the law extending neonatal screenings. Through deliberative debates, highlights of the newly updated kit-PlayDecide ORPHAN DRUGS, in regions where training and community-building are key to consolidating the cycle of early diagnosis and access to appropriate therapy: patients, caregivers, future parents, students, researchers, health professionals, industry, institutions and communication representatives, analyse these issues of great complexity and high impact on the quality of life together .
September 28, 2016
MassBio is pleased to announce the 3rd Annual Patient Advocacy Summit This event brings industry leaders together with patient advocates and other stakeholders to examine ways in which life sciences companies can more fully incorporate the patient voice into the work they do— not just approaching regulatory applications or at commercialization, but throughout the drug development cycle. The day-long event will include panel discussions, case study presentations (spotlighting industry/patient partnerships), a keynote address, and awards ceremony, as well as a networking breakfast, lunch and cocktail reception. Expected attendance is 180 participants in person and an additional online streaming audience of 50+ patient advocacy professionals, patient organizations and other stakeholders.
September 30, 2016
The Life Science Association of Manitoba (LSAM) is the voice and organizational nucleus of Manitoba’s life science industry. Since 1990, it's come to represent over 110 local organizations that span across Manitoba’s health, bioproduct, and food and agriculture sectors.
September 22, 2016
It's Alive – Bacteria and Yeast and Technology?! Oh My! Experiments and activities; cash bar available. Admission: $10 per person NOTE: Adult Science Nights are licensed events and only those 19 years and older All visitors must provide valid, government issued photo ID.are able to attend.
September 28, 2016
The Accel-Rx Health Sciences Accelerator is a national organization focused on maximizing new health sciences company creation, and ensuring start-ups have the resources they need to enable them to stay and grow in Canada and become a new generation of strong health sciences anchor companies. Join us for our Open House.
September 26, 2016
Start the week off with a hearty breakfast that showcases Saskatchewan innovations in food ingredients, followed by tours of select Innovation Place bioscience companies. Candle-Span Room, The Atrium, Innovation Place. This is a free event, but seating is limited and registration is required.
September 21, 2016
This conference focuses on using animal biotechnology to advance the objectives of One Health. The tools of biotechnology are uniquely suited to address challenges at the nexus of human, animal and environmental health. Topics to be discussed include biotechnology applications and policy issues associated with emerging infectious diseases, animal models of human diseases, food safety, biodefense, agricultural productivity, biodiversity conservation, and animal health and welfare.
September 30, 2016
Video screening, Q&A and discussion. STUDENTS: Join us for a screening of SaskCanola’s documentary “License to Farm†followed by a discussion with some of the experts featured in the video! Social license is a fascinating and complex topic which can affect research funding and policy, and maybe YOUR career! Join the conversation!
September 27, 2016
Plan to attend the 2016 Global Biotechnology Week Breakfast. Canada is home to a vibrant biotech industry of more than 500 established and emerging companies. These companies are driving solutions for the challenges identified with global population growth including vaccines protecting against cancer, green chemicals offering options for environmental stewardship, and more sustainable farming practices to secure food supply. It is an industry of great diversity with an array of entities including large, multinational companies as well as numerous small and medium sized companies.
September 27, 2016
2016 is a turning point for orphan drugs and for neonatal screenings. In Europe the benefit of orphan drug designation is debated, whilst in Italy a scientific inclusive environment is pushing for the finalisation of the law extending neonatal screenings. Through deliberative debates, highlights of the newly updated kit-PlayDecide ORPHAN DRUGS, in regions where training and community-building are key to consolidating the cycle of early diagnosis and access to appropriate therapy: patients, caregivers, future parents, students, researchers, health professionals, industry, institutions and communication representatives, analyse these issues of great complexity and high impact on the quality of life together .
September 28, 2016
MassBio is pleased to announce the 3rd Annual Patient Advocacy Summit This event brings industry leaders together with patient advocates and other stakeholders to examine ways in which life sciences companies can more fully incorporate the patient voice into the work they do— not just approaching regulatory applications or at commercialization, but throughout the drug development cycle. The day-long event will include panel discussions, case study presentations (spotlighting industry/patient partnerships), a keynote address, and awards ceremony, as well as a networking breakfast, lunch and cocktail reception. Expected attendance is 180 participants in person and an additional online streaming audience of 50+ patient advocacy professionals, patient organizations and other stakeholders.
September 30, 2016
The Life Science Association of Manitoba (LSAM) is the voice and organizational nucleus of Manitoba’s life science industry. Since 1990, it's come to represent over 110 local organizations that span across Manitoba’s health, bioproduct, and food and agriculture sectors.
September 22, 2016
It's Alive – Bacteria and Yeast and Technology?! Oh My! Experiments and activities; cash bar available. Admission: $10 per person NOTE: Adult Science Nights are licensed events and only those 19 years and older All visitors must provide valid, government issued photo ID.are able to attend.
September 28, 2016
The Accel-Rx Health Sciences Accelerator is a national organization focused on maximizing new health sciences company creation, and ensuring start-ups have the resources they need to enable them to stay and grow in Canada and become a new generation of strong health sciences anchor companies. Join us for our Open House.
September 26, 2016
Start the week off with a hearty breakfast that showcases Saskatchewan innovations in food ingredients, followed by tours of select Innovation Place bioscience companies. Candle-Span Room, The Atrium, Innovation Place. This is a free event, but seating is limited and registration is required.
September 21, 2016
This conference focuses on using animal biotechnology to advance the objectives of One Health. The tools of biotechnology are uniquely suited to address challenges at the nexus of human, animal and environmental health. Topics to be discussed include biotechnology applications and policy issues associated with emerging infectious diseases, animal models of human diseases, food safety, biodefense, agricultural productivity, biodiversity conservation, and animal health and welfare.